JP2003522147A5 - - Google Patents

Download PDF

Info

Publication number
JP2003522147A5
JP2003522147A5 JP2001557563A JP2001557563A JP2003522147A5 JP 2003522147 A5 JP2003522147 A5 JP 2003522147A5 JP 2001557563 A JP2001557563 A JP 2001557563A JP 2001557563 A JP2001557563 A JP 2001557563A JP 2003522147 A5 JP2003522147 A5 JP 2003522147A5
Authority
JP
Japan
Prior art keywords
mirtazapine
treatment
sleep disorder
medicament
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001557563A
Other languages
English (en)
Other versions
JP2003522147A (ja
JP5039994B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/001221 external-priority patent/WO2001058453A1/en
Publication of JP2003522147A publication Critical patent/JP2003522147A/ja
Publication of JP2003522147A5 publication Critical patent/JP2003522147A5/ja
Application granted granted Critical
Publication of JP5039994B2 publication Critical patent/JP5039994B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項1】 睡眠障害の治療用の医薬の製造のためのミルタザピンの使用であって、該治療が、0.1〜5mgのミルタザピンを含む単位治療量でミルタザピンを投与することを含むことを特徴とする使用。
【請求項2】 該睡眠障害が一次性不眠症である、請求項1記載の使用。
JP2001557563A 2000-02-11 2001-02-06 睡眠障害の治療のためのミルタザピンの使用 Expired - Lifetime JP5039994B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200499 2000-02-11
EP00200499.2 2000-02-11
PCT/EP2001/001221 WO2001058453A1 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Publications (3)

Publication Number Publication Date
JP2003522147A JP2003522147A (ja) 2003-07-22
JP2003522147A5 true JP2003522147A5 (ja) 2008-03-13
JP5039994B2 JP5039994B2 (ja) 2012-10-03

Family

ID=8171013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001557563A Expired - Lifetime JP5039994B2 (ja) 2000-02-11 2001-02-06 睡眠障害の治療のためのミルタザピンの使用

Country Status (25)

Country Link
US (1) US6933293B2 (ja)
EP (4) EP1656937A1 (ja)
JP (1) JP5039994B2 (ja)
KR (1) KR20020069371A (ja)
CN (2) CN1395487A (ja)
AR (1) AR027394A1 (ja)
AT (1) ATE317261T1 (ja)
AU (1) AU780439B2 (ja)
BR (1) BR0108261A (ja)
CA (1) CA2396209C (ja)
CO (1) CO5271706A1 (ja)
CZ (1) CZ302368B6 (ja)
DE (1) DE60117122T2 (ja)
DK (1) DK1257278T3 (ja)
ES (1) ES2258071T3 (ja)
HK (1) HK1049122B (ja)
HU (1) HUP0204391A3 (ja)
IL (2) IL150290A0 (ja)
NO (1) NO328007B1 (ja)
PE (1) PE20011080A1 (ja)
PL (1) PL206073B1 (ja)
RU (1) RU2270680C2 (ja)
SK (1) SK287396B6 (ja)
WO (1) WO2001058453A1 (ja)
ZA (1) ZA200205238B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1689371A2 (en) * 2003-11-25 2006-08-16 Aurobindo Pharma Limited Pharmaceutical compositions of mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
KR100870381B1 (ko) * 2004-10-14 2008-11-25 다이킨 고교 가부시키가이샤 분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
CA2684021A1 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of an enantiomer of a tetracyclic benzazepine
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
EP0813873B1 (en) 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
CN1154495C (zh) * 1997-11-14 2004-06-23 阿克佐诺贝尔公司 米氮平用于治疗睡眠性呼吸暂停的用途

Similar Documents

Publication Publication Date Title
IL273765A (en) Combinations and forms of administration of therapeutic agents and combined treatment
JP2003503454A5 (ja)
YU30004A (sh) Upotreba flibanserina u lečenju seksualnih poremećaja
JP2006501240A5 (ja)
NO20014519D0 (no) Apomorfin- og sildenafilpreparat
HK1087025A1 (en) Use of immunomudulatory compounds in preparation of a medicament for treating, preventing or managing myeloproliferative diseases
IL151164A0 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
AU1249902A (en) Effective antitumour treatments
JP2003522147A5 (ja)
JP2005507892A5 (ja)
JP2005500277A5 (ja)
JP2003514025A5 (ja)
CA2396209A1 (en) The use of mirtazapine for the treatment of sleep disorders
SE9902597D0 (sv) New use
JP2003501387A5 (ja)
JP2005505605A5 (ja)
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
EP1622450A4 (en) PROCESS FOR PROMOTING UNINTERRUPTED SLEEP BY ADMINISTERING TROPIUM CHLORIDE
JP2001316293A5 (ja)
JP2002501021A5 (ja)
IL151627A0 (en) Divided dose therapies with vascular damaging activity
JP2004513150A5 (ja)
CN201337222Y (zh) 多功能枕头
CN203789587U (zh) 一种新型医疗保健枕
JP2004262775A5 (ja)